Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) was $7.24 for the day, up 6.00% from the previous closing price of $6.83. In other words, the price has increased by $6.00 from its previous closing price. On the day, 1.95 million shares were traded. AVAH stock price reached its highest trading level at $7.255 during the session, while it also had its lowest trading level at $6.8205.
Ratios:
Our analysis of AVAH’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.01 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.11. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.09.
On July 02, 2025, Barclays started tracking the stock assigning a Equal Weight rating and target price of $5.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 13 ’25 when Cunningham Patrick A. sold 18,500 shares for $4.93 per share. The transaction valued at 91,174 led to the insider holds 327,869 shares of the business.
J.H. Whitney Equity Partners V sold 750,000 shares of AVAH for $3,900,000 on Jun 10 ’25. The 10% Owner now owns 28,890,756 shares after completing the transaction at $5.20 per share. On Jun 10 ’25, another insider, VIGANO PAUL R, who serves as the 10% Owner of the company, sold 750,000 shares for $5.20 each. As a result, the insider received 3,900,000 and left with 28,890,756 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVAH now has a Market Capitalization of 1512407040 and an Enterprise Value of 2902919680. As of this moment, Aveanna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 96.28, and their Forward P/E ratio for the next fiscal year is 17.49. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.69. Its current Enterprise Value per Revenue stands at 1.333 whereas that against EBITDA is 12.503.
Stock Price History:
The Beta on a monthly basis for AVAH is 1.93, which has changed by 0.580786 over the last 52 weeks, in comparison to a change of 0.18157876 over the same period for the S&P500. Over the past 52 weeks, AVAH has reached a high of $6.98, while it has fallen to a 52-week low of $3.67. The 50-Day Moving Average of the stock is 53.96%, while the 200-Day Moving Average is calculated to be 47.79%.
Shares Statistics:
AVAH traded an average of 802.76K shares per day over the past three months and 2340170 shares per day over the past ten days. A total of 208.26M shares are outstanding, with a floating share count of 44.84M. Insiders hold about 78.53% of the company’s shares, while institutions hold 21.48% stake in the company. Shares short for AVAH as of 1753920000 were 2175443 with a Short Ratio of 2.71, compared to 1751241600 on 2002220. Therefore, it implies a Short% of Shares Outstanding of 2175443 and a Short% of Float of 3.2.
Earnings Estimates
The current market rating for Aveanna Healthcare Holdings Inc (AVAH) reflects the collective analysis of 8.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.07, with high estimates of $0.08 and low estimates of $0.05.
Analysts are recommending an EPS of between $0.45 and $0.39 for the fiscal current year, implying an average EPS of $0.42. EPS for the following year is $0.41, with 9.0 analysts recommending between $0.57 and $0.16.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 7 analysts. It ranges from a high estimate of $589.71M to a low estimate of $566.8M. As of the current estimate, Aveanna Healthcare Holdings Inc’s year-ago sales were $509.02MFor the next quarter, 7 analysts are estimating revenue of $584.38M. There is a high estimate of $599.53M for the next quarter, whereas the lowest estimate is $578.5M.
A total of 7 analysts have provided revenue estimates for AVAH’s current fiscal year. The highest revenue estimate was $2.32B, while the lowest revenue estimate was $2.3B, resulting in an average revenue estimate of $2.31B. In the same quarter a year ago, actual revenue was $2.02BBased on 8 analysts’ estimates, the company’s revenue will be $2.44B in the next fiscal year. The high estimate is $2.52B and the low estimate is $2.29B.
